Clinical Trials Directory

Trials / Unknown

UnknownNCT03384355

Ecchymosis and Coldness in Patients With Varicose Vein

Ecchymosis and Coldness in Patients With Varicose Vein: Multicenter Study of Modified VEIN-Sym QoL Assessment

Status
Unknown
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
Vascular and Molecular Cardiology Society · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

In this prospective, observational study, the investigators aim to investigate the symptoms of varicose vein patients.

Detailed description

Chronic venous disease is very common in all over the world and affects both the mortality and morbidity depending on the effected vascular territory. It is often overlooked by healthcare professionals due to the underestimation of the prevalence and impact of the disease. It represents a spectrum of conditions varying from simple telangiectasia or reticular veins to skin fibrosis and venous ulceration. The main clinical characteristics are dilated veins, edema, leg pain, and cutaneous alterations in the legs. Varicose veins are dilating superficial veins, which become more tortuous and enlarged, continuously. Chronic venous disease affects the life quality of patients suffering from the disease, which can be measured with quality-of-life reports. Venous Insufficiency Epidemiological and Economic Study-Quality of Life/Symptoms (VEINES-QoL/Sym) questionnaire is a patient based, designed for self-completion instrument to measure both the symptom severity and quality of life. VEINES-QOL measures life quality and VEINES-Sym provides an overall estimate of CVD symptom frequency. From the practitioners daily knowledge of patients with varicose veins, there is a significant proportion of varicose vein patients also suffering from symptoms such as coldness and ecchymosis. In this context, the investigators aim to investigate the symptoms of participants with varicose vein using the VEINES-Sym questionnaire.

Conditions

Timeline

Start date
2018-01-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2017-12-27
Last updated
2017-12-27

Source: ClinicalTrials.gov record NCT03384355. Inclusion in this directory is not an endorsement.